Edmonds Duncan Registered Investment Advisors LLC Has $476,000 Holdings in Colgate-Palmolive Company (CL)
Edmonds Duncan Registered Investment Advisors LLC held its position in shares of Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,423 shares of the company’s stock at the end of the second quarter. Edmonds Duncan Registered Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $476,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. American Beacon Advisors Inc. bought a new position in Colgate-Palmolive during the first quarter valued at $102,000. Proficio Capital Partners LLC raised its stake in shares of Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after acquiring an additional 207 shares during the period. OLD Second National Bank of Aurora purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at $109,000. Hanson & Doremus Investment Management raised its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares during the period. Finally, Harbour Capital Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at $121,000. Institutional investors and hedge funds own 73.87% of the company’s stock.
In other Colgate-Palmolive news, CMO Mukul Deoras sold 7,500 shares of the firm’s stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the transaction, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total transaction of $660,690.00. The disclosure for this sale can be found here. Insiders have sold a total of 173,673 shares of company stock worth $12,629,293 in the last three months. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (NYSE CL) opened at $71.89 on Friday. The company has a market cap of $63,780.00, a PE ratio of 25.60, a P/E/G ratio of 3.36 and a beta of 0.80. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.73 EPS. analysts forecast that Colgate-Palmolive Company will post 2.88 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.
CL has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research note on Monday, October 23rd. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $75.00 to $84.00 in a research note on Monday, September 25th. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research note on Sunday, October 29th. Finally, SunTrust Banks, Inc. raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their target price for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $76.67.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.